Summary
GE HealthCare Technologies Inc. (GEHC) announced on March 12, 2024, the commencement and pricing of an underwritten offering of 14,000,000 shares of its common stock. Importantly, GEHC itself is not selling any shares and will not receive any proceeds from this offering. Instead, the shares being sold originate from General Electric Company (GE). Prior to the sale, GE is expected to exchange these shares for its own indebtedness held by Morgan Stanley Bank, N.A. Subsequently, Morgan Stanley & Co. LLC, acting as the selling stockholder, will sell the shares to the underwriter. This transaction is part of GE's broader strategy to divest its stake in GEHC, and investors should note that the share price and the total amount raised will be determined by the market and the underwriter, not directly by GEHC. The company has also provided standard forward-looking statements related to the offering.
Key Highlights
- 1GE HealthCare is not selling shares and will not receive proceeds from the offering.
- 2The offering involves 14,000,000 shares of GEHC common stock.
- 3General Electric Company (GE) will exchange GEHC shares for its own indebtedness with Morgan Stanley Bank, N.A.
- 4Morgan Stanley & Co. LLC is the designated selling stockholder and underwriter.
- 5The underwriter has an option to purchase additional shares.
- 6The transaction is governed by an Underwriting Agreement dated March 12, 2024.
- 7The filing includes standard forward-looking statements and risk factor disclosures.